We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Noninvasive Cancer Diagnosis with a Contact Lens-based System that Collects and Analyses Tear Exosomes

By LabMedica International staff writers
Posted on 12 Aug 2022
Print article
Image: Researchers have developed a novel type of contact lens that can capture and analyze tears for the detection of exosomes, which have the potential for being diagnostic cancer biomarkers (Photo courtesy of Terasaki Institute for Biomedical Innovation)
Image: Researchers have developed a novel type of contact lens that can capture and analyze tears for the detection of exosomes, which have the potential for being diagnostic cancer biomarkers (Photo courtesy of Terasaki Institute for Biomedical Innovation)

A novel contact lens-based system for noninvasive cancer screening and diagnosis concentrates and analyzes exosomes shed by cancer cells into tears.

Exosomes are formed within most cells and secreted into many bodily fluids, such as plasma, saliva, urine, and tears. They are lipid-bilayer-enclosed structures, with sizes ranging from 30 to 5,000 nanometers. In the past decade, exosomes have emerged as important mediators of cell communication because they serve as vehicles for the intercellular transmission of biological signals (proteins or nucleic acids) capable of altering cell function and physiology. In addition, exosomes related to cancers have been reported to exist in tears.

The use of exosomes for clinical purposes has been hindered by difficulty in isolating them in sufficient quantity and purity. Current methods involve tedious and time-consuming ultracentrifuge and density gradient techniques, lasting at least ten hours to complete.

To overcome this shortcoming, investigators at Terasaki Institute for Biomedical Innovation (Los Angeles, CA, USA) developed a poly(2-hydroxyethyl methacrylate) contact lens embedded with antibody-conjugated signaling microchambers (ACSM-PCL) capable of detecting tear exosomes. Microchamber surfaces were chemically modified to activate them for antibody binding, and procedures were optimized for binding a capture antibody to the ACSM-CL microchambers and a different (positive control) detection antibody onto gold nanoparticles that could be visualized spectroscopically.

Results revealed that the ACSM-PCL could detect exosomes in the pH range of 6.5–7.4 (similar to the pH of human tears). In particular, the ACSM-PCL could detect exosomes in various solutions, including regular buffer, cell culture media from various cell lines, and human tears. Furthermore, the ACSM-PCL could differentiate expression of exosome surface proteins thought to be cancer biomarkers.

The ACSM-CL was tested against exosomes secreted into supernatants from ten different tissue and cancer cell lines. The ability to capture and detect exosomes was validated by the spectroscopic shifts observed in all the test samples, in comparison with the negative controls. Similar results were obtained when the ACSM-CL was tested against ten different tear samples collected from volunteers.

“Exosomes are a rich source of markers and biomolecules which can be targeted for several biomedical applications,” said senior author Dr. Ali Khademhosseini, director and CEO of Terasaki Institute for Biomedical Innovation. “The methodology that our team has developed greatly facilitates our ability to tap into this source.”

The contact lens system for capture of exosomes from tears was described in the August 10, 2022, online edition of the journal Advanced Functional Materials.

Related Links:
Terasaki Institute for Biomedical Innovation

 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.